Read news on Evolocumab with our app.
Read more in the app
LDL cholesterol lowering with evolocumab before percutaneous coronary intervention for acute myocardial infarction (AMUNDSEN)
Evolocumab to reduce first major cardiovascular events in patients without known significant atherosclerosis and with diabetes - EurekAlert!
Evolocumab did not improve vein graft disease following coronary artery bypass surgery - EurekAlert!
